Carolyn Majcher, OD, FAAO, discussed the impact of the FDA's approval of the drug for wet AMD after nearly 2 decades of off-label use.
Northeastern State University - Oklahoma College of Optometry
Latest Content
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: The human cost of dry eye
2
AAOpt 2026: How DOT lenses affect children’s everyday vision
3
Aldeyra to appeal FDA rejection of reproxalap as a treatment for dry eye disease
4
Johnson & Johnson Acuvue Oasys lenses demonstrate favorable moisture retention
5